Navigation Links
Envera Appoints Michael McErlean Fermentation Manager

West Chester, PA (PRWEB) May 22, 2013

Envera announced today that Michael McErlean has joined the company as Fermentation Manager. Mr. McErlean has an extensive background in cell production and served in a variety of leadership positions throughout his career.

Mike Matheny, President and Owner of Envera stated, “We are very pleased to have Mike join our team”. “Mike’s background is perfectly suited to oversee our newly installed large scale fermentation and downstream processing equipment”, added Matheny. “Mike’s hands on experience optimizing production protocols, establishing preventative maintenance procedures, and troubleshooting equipment is exactly what we need for this stage of Envera’s growth”, concluded Matheny.

Mr. McErlean holds a Bachelor’s Degree from Millersville University. Mike’s professional career includes 18 years of experience divided between Centocor, Merck Sharp & Dohme, and Fibrocell Science. During his time with these companies Mike gained hands on experience running a variety of bioreactors and downstream equipment as well as the implementation of new procedures and processes. Michael was also responsible for the generation of SOP’s, departmental logistics, and Quality/Regulatory issues.

“I am pleased to join a technology based company that is making a difference in the world”, stated McErlean. “Envera’s focus on using naturally occurring microorganisms to replace harsh chemicals, remediate environmental waste, and promote the growth and health of plants and animals was particularly appealing to me”, added Mike. “I am eager to utilize the newly installed fermentation and downstream processing equipment to support Envera’s expanding business”, finished McErlean.

Mr. McErlean will be located at Envera’s West Chester, Pennsylvania corporate offices and can be reached at 484-593-4002 or mmcerlean(at)envera(dot)com.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Envera Increases Scientific Staff
2. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
3. Elsevier / MEDai Appoints Tom Zajac as New President
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
6. BioStorage Technologies Appoints New Member to Board of Directors
7. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
8. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
9. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
10. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
11. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):